| « Previous month | Next month » |
Researchers have developed a new laboratory technique, which allows them to change sequences within a DNA molecule. The tool is set to have positive implications in DNA lab-based medical diagnosis and nanobiotechnology.
A set of laboratory instruments can measure egg quality within minutes,allowing plant managers to save time on the processing line.
Cellectricon has launched a new chip for safety pharmacology and hERG studies, which aims to provide a solution to the current need for increased throughput and data quality in ion channel drug discovery that has plagued drug researchers.
Bayer Diagnostics launches its latest immunoassay system, part of its ADVIA family of automated clinical laboratory solutions, which enable laboratories to rapidly perform a wide variety of disease-specific tests which enhance the management of disease.
The world's first commercial-scale continuous sonocrystallisation system promises to revolutionise the way crystals are processed in pharmaceutical manufacturing.
Using a modular system of radio frequency identification (RFID) tags and a new set of software Escort Memory Systems says it has developed an faster way to ensure automated tasks are triggered quicker on fast moving production lines.
An ultrasonic meter clamps on to piping to accurately measure flow rates of liquid used in the food processing industry.
Merck has announced that its chairman of the executive board, Bernhard Scheuble is to leave the company, by mutual agreement, in a surprise departure considering the company's performance, especially in its liquid crystals unit.
Degussa have discovered a catalyst that improves the efficiency of reductive carbonylation reactions and will provide greater access to new active pharmaceutical ingredients (APIs).
A US district court has denied a motion by Bio-Rad Laboratories to enforce an alleged settlement agreement with Applied Biosystems meaning the life science research product provider cannot continue selling its thermal cycler products.
GenoID has announced a breakthrough in human papillomavirus (HPV) testing with the first ever laboratory test kit that uses a real-time polymerase chain reaction (real-time PCR) method to detect all virus variants that cause cervical cancer.
Sweden-based Gyros' laboratory automation system has received an endorsement from analyst Frost & Sullivan, which has awarded the company the top prize in the category for this year's annualinnovation awards.
The need to analyse voluminous data is set to create a wealth of opportunities for bioinformatics in which systems integration capabilities are predicted to boost uptake of bioinformatics and clinical informatics in drug discovery and development.
A new class of chiral stationary phases (CSPs) for analytical and preparative-scale high performance liquid chromatography (HPLC), has been launched by ZirChrom Separations, which further enhances HPLC as a method of choice for chiral pharmaceuticals.
Solvias debuted its new 80-member ligand kit at CPhI 2005, offering manufacturers increased flexibility in active pharmaceutical ingredient (API) development and manufacturing.
Novozymes' enzymatic interesterification process has been recognised as one of six Technologies of the Year for 2005.
Degussa used CPhI in Madrid to preview its new flow distributor, which reduces the time it takes manufacturers to remove unwanted transition metals from active pharmaceutical ingredients (APIs), by eliminating the filtration step.
The Association of the British Pharmaceutial Industry (ABPI) has revealed a new code of practice for the pharmaceutical industry, with an emphasis on patient safety especially material detailing information about reporting adverse drug reactions.
Israel Chemicals (ICL's) acquisition of US speciality phosphates firm Astaris will give the firm a foothold in the lucrative North American ingredients market.
Omron has added an anti-bacterial housing for its line of inductive proximity sensors in a bid to ensure they do not transfer bacterial contamination when used in food and drink plants.
Innovative laboratory technology that produces a sharper picture of the nano-machine that translates genetic program into proteins gives a unique insight into how some types of antibiotics work leading to the design of better ones.
A group of researchers have found that FLT-1 - a molecule implicated in blood vessel growth - is necessary for the escape of the leukaemia cells from the bone marrow (BM), suggesting that blocking of this molecule pharmaceutically might be used in the treatment of leukaemia.
According to a recent report, analytic separation technology will continue to evolve as limitations are addressed and standards grow even more rigorous, as market drivers such as quality control, instrument design, and software in the biotech/health care industry continue to promote its evolution.
Kreatech Biotechnology launches its latest small RNA kit that targets microRNA and siRNA arrays that directly labels any and all sizes of naturally occurring nucleic acids without the need of enzymes.
Pall Corporation has revealed a unique approach for speeding vaccine production, which could provide a solution to the potentially huge demand for vaccines by governments and pharmaceutical manufacturers in response to the avian flu crisis.
Non-contact "rod-style" sensors for gauging liquid levels in tanks have been designed for the food industry.
Foss has introduced the latest in its NIRSystems analyser range, featuring the company's XDS near-infrared (NIR) technology, for improved analytical performance in harsh industrial manufacturing environments.
Nikon Instruments have launched a series of software and application enhancements for spectral imaging applications, which are used extensively in drug discovery and cell biology.
Following the European Union's objectives to totally eliminate all testing of cosmetic ingredients on animals, the European cosmetics association, Colipa, says that an industry-wide partnership has been forged with the objective to reduce and eventually replace all laboratory animal testing.
A diagnostic test, which monitors anti-HIV drugs in the blood, is set to enter development to eventually become available across Europe. The test will be used to identify the correct dosage of medicine for individual patients.
Biochip technology has redefined the process of drug discovery with partnerships central to accelerating adoption levels and expanding revenues in a market that is reinforced by strong bioinformatics infrastructure and standardisation of array platforms.
The emphasis on food safety in the plant has led one company to see a market for pens that inhibit bacterial build-up.
The French group launched its first dairy research centre in Asia at the same time as raising its stake in China's Bright Dairy & Food Co to 11.55 per cent.
The EFSA believes that a new approach to the assessment of genotoxic and carcinogenic substances is vital to ensure EU food safety.
Three new sensors allow wine makers to monitor colour and to trace the results of altering different factors during the processing of their product.
The world's first and only radio frequency identification (RFID) smart cap, originally designed for drug trial compliance monitoring, is being re-launched as an anti-counterfeiting tool.
According to a new report, more than 400 new medicines are in development to treat diseases that affect US women, including 62 medicines now in testing to treat breast cancer.
Yesterday's launch of the EU-funded Yeast Systems Biology Network could eventually help European yeast producers fight off the growing challenge from China.
Troubled firm Flamel reported a sharp decrease in total third quarter revenues - $3.1 million (€2.6 million), compared to $13.3 million this time last year - resulting in a net loss $11.9 million.
Lonza and Solvias have confirmed their long-term collaboration in the development and transfer of asymmetric reactions to an industrial scale.
According to a new study, the worldwide market for in vitro cancer diagnosis will reach the $7.4 billion (€6.1 billion) mark by 2009, as the demand for such tests will continue to increase as new cancer cases soars toward the 10 million mark.
Simulations Plus has announced the release of a new hERG potassium channel blocking affinity model that extends the capabilities of its ADMET Predictor software in the area of cardiac drug toxicity.
Now that the US authorities have issued final guidance under the Bioterrorism Act, companies can now have assurance about the food safety systems they have implemented or are about to put in place, and the costs involved in complying with the act.
Viscotek launches its latest entry-level system for laboratories looking to conduct characterisation of proteins, and other biomolecules, allowing researchers to make a determination of absolute Molecular Weight, a traditionally time consuming process.
| « Previous month | Next month » |